| Numéro index | Identification chimique internationale | Numéros CE | Numéros CAS | Classification | Étiquetage |
Limites de concentrations spécifiques,
facteurs M
| Notes
| Code(s) des classes et catégories de danger | Code(s) des mentions de danger | Code(s) des pictogrammes, mentions d’avertissement | Code(s) des mentions de danger | Code(s) des mentions additionnelles de danger
| 031-001-00-4 | gallium arsenide | 215-114-8 | 1303-00-0 | Carc. 1B | H350 | GHS08 | H350 | | |
| STOT RE 1 | H372 (systèmes respiratoire et hématopoïétique) | Dgr | H372 (systèmes respiratoire et hématopoïétique)
| 050-025-00-6 | trichloromethylstannane | 213-608-8 | 993-16-8 | Repr. 2 | H361d |
GHS08
Wng
| H361d | | |
| 050-026-00-1 | 2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 260-828-5 | 57583-34-3 | Repr. 2 | H361d |
GHS08
Wng
| H361d | | |
| 050-027-00-7 | 2-ethylhexyl 10-ethyl-4,4-dioctyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate | 239-622-4 | 15571-58-1 | Repr. 1B | H360D |
GHS08
Dgr
| H360D | | |
| 601-087-00-3 | 2,4,4-trimethylpentene | 246-690-9 | 25167-70-8 | Flam. Liq. 2 | H225 | GHS02 | H225 | | | D
| Asp. Tox. 1 | H304 | GHS07 | H304
| STOT SE 3 | H336 |
GHS08
Dgr
| H336
| 606-145-00-1 |
sulcotrione (ISO);
2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione
| | 99105-77-8 | Repr. 2 | H361d | GHS08 | H361d | |
M = 1
M = 10
|
| STOT RE 2 | H373 (reins) | GHS07 | H373 (reins)
| Skin Sens. 1A | H317 | GHS09 | H317
| Aquatic Acute 1 | H400 | Wng |
| Aquatic Chronic 1 | H410 | | H410
| 607-699-00-7 |
bifenthrin (ISO);
(2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylate
| | 82657-04-3 | Carc. 2 | H351 | GHS06 | H351 | |
M = 10 000
M = 100 000
|
| Acute Tox. 3 | H331 | GHS08 | H331
| Acute Tox. 2 | H300 | GHS09 | H300
| STOT RE 1 | H372 (système nerveux) | Dgr | H372 (système nerveux)
| Skin Sens. 1B | H317 | | H317
| Aquatic Acute 1 | H400 | |
| Aquatic Chronic 1 | H410 | | H410
| 607-700-00-0 |
indoxacarb (ISO);
methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1]
| | 173584-44-6 [1] | Acute Tox. 3 | H301 | GHS06 | H301 | |
M = 1
M = 1
|
| Acute Tox. 4 | H332 | GHS08 | H332
| STOT RE 1 | H372 (sang, système nerveux, cœur) | GHS09 | H372 (sang, système nerveux, cœur)
| Skin Sens. 1B | H317 | Dgr | H317
| Aquatic Acute 1 | H400 | |
| Aquatic Chronic 1 | H410 | | H410
|
reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25;
methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [2]
| 144171-61-9 [2] | | | |
| 607-702-00-1 | dihexyl phthalate | 201-559-5 | 84-75-3 | Repr. 1B | H360FD |
GHS08
Dgr
| H360FD | | |
| 607-703-00-7 | ammoniumpentadeca- fluorooctanoate | 223-320-4 | 3825-26-1 | Carc. 2 | H351 | GHS08 | H351 | | |
| Repr. 1B | H360D | GHS07 | H360D
| Lact. | H362 | GHS05 | H362
| Acute Tox. 4 | H332 | Dgr | H332
| Acute Tox. 4 | H302 | | H302
| STOT RE 1 | H372 (foie) | | H372 (foie)
| Eye Dam.1 | H318 | | H318
| 607-704-00-2 | perfluorooctanoic acid | 206-397-9 | 335-67-1 | Carc. 2 | H351 | GHS08 | H351 | | |
| Repr. 1B | H360D | GHS07 | H360D
| Lact. | H362 | GHS05 | H362
| Acute Tox. 4 | H332 | Dgr | H332
| Acute Tox. 4 | H302 | | H302
| STOT RE 1 | H372 (foie) | | H372 (foie)
| Eye Dam. 1 | H318 | | H318
| 612-282-00-8 | octadecylamine | 204-695-3 | 124-30-1 | Asp. Tox. 1 | H304 | GHS05 | H304 | |
M = 10
M = 10
|
| STOT RE 2 | H373 (appareil digestif, foie, système immunitaire) | GHS08 | H373 (appareil digestif, foie, système immunitaire)
| Skin Irrit. 2 | H315 | GHS09 | H315
| Eye Dam. 1 | H318 | Dgr | H318
| Aquatic Acute 1 | H400 | |
| Aquatic Chronic 1 | H410 | | H410
| 612-283-00-3 | (Z)-octadec-9-enylamine | 204-015-5 | 112-90-3 | Acute Tox. 4 | H302 | GHS05 | H302 | |
M = 10
M = 10
|
| Asp Tox. 1 | H304 | GHS07 | H304
| STOT SE 3 | H335 | GHS08 | H335
| STOT RE 2 | H373 (appareil digestif, foie, système immunitaire) | GHS09 | H373 (appareil digestif, foie, système immunitaire)
| Skin Corr. 1B | H314 | Dgr | H314
| Aquatic Acute 1 | H400 | |
| Aquatic Chronic 1 | H410 | | H410
| 612-284-00-9 | amines, hydrogenated tallow alkyl | 262-976-6 | 61788-45-2 | Asp Tox. 1 | H304 | GHS08 | H304 | |
M = 10
M = 10
|
| STOT RE 2 | H373 (appareil digestif, foie, système immunitaire) | GHS05 | H373 (appareil digestif, foie, système immunitaire)
| Skin Irrit. 2 | H315 | GHS09 | H315
| Eye Dam. 1 | H318 | Dgr | H318
| Aquatic Acute 1 | H400 | |
| Aquatic Chronic 1 | H410 | | H410
| 612-285-00-4 | amines, coco alkyl | 262-977-1 | 61788-46-3 | Acute Tox. 4 | H302 | GHS05 | H302 | |
M = 10
M = 10
|
| Asp. Tox. 1 | H304 | GHS07 | H304
| STOT SE 3 | H335 | GHS08 | H335
| STOT RE 2 | H373 (appareil digestif, foie, système immunitaire) | GHS09 | H373 (appareil digestif, foie, système immunitaire)
| Skin Corr. 1B | H314 | Dgr | H314
| Aquatic Acute 1 | H400 | |
| Aquatic Chronic 1 | H410 | | H410
| 612-286-00-X | amines, tallow alkyl | 263-125-1 | 61790-33-8 | Acute Tox. 4 | H302 | GHS05 | H302 | |
M = 10
M = 10
|
| Asp. Tox. 1 | H304 | GHS07 | H304
| STOT RE 2 | H373 (appareil digestif, foie, système immunitaire) | GHS08 | H373 (appareil digestif, foie, système immunitaire)
| Skin Corr. 1B | H314 | GHS09 | H314
| Aquatic Acute 1 | H400 | Dgr |
| Aquatic Chronic 1 | H410 | | H410
| 616-206-00-4 |
flufenoxuron (ISO);
1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea
| 417-680-3 | 101463-69-8 | Lact. | H362 | GHS09 | H362 | |
M = 10 000
M = 10 000
|
| Aquatic Acute 1 | H400 | Wng |
| Aquatic Chronic 1 | H410 | | H410
| 616-207-00-X | polyhexamethylene biguanide hydrochloride | | 27083-27-8 or 32289-58-0 | Carc. 2 | H351 | GHS05 | H351 | |
M = 10
M = 10
|
| Acute Tox. 4 | H302 | GHS07 | H302
| STOT RE 1 | H372 (voies respiratoires) (inhalation) | GHS08 | H372 (voies respira- toires) (inhalation)
| Eye Dam. 1 | H318 | GHS09 | H318
| Skin Sens. 1B | H317 | Dgr | H317
| Aquatic Acute 1 | H400 | |
| Aquatic Chronic 1 | H410 | | H410
| 616-208-00-5 |
N-ethyl-2-pyrrolidone;
1-ethylpyrrolidin-2-one
| 220-250-6 | 2687-91-4 | Repr. 1B | H360D |
GHS08
Dgr
| H360D | | |
| 616-209-00-0 |
amidosulfuron (ISO);
3-(4,6-dimethoxypyrimidin-2-yl)-1-[(N-methyl-N-methylsulfonylamino)sulfonyl]urea
| 407-380-0 | 120923-37-7 | Aquatic Acute 1 | H400 | GHS09 | | |
M = 100
M = 100
|
| Aquatic Chronic 1 | H410 | Wng | H410
| 616-210-00-6 |
tebufenpyrad (ISO); N-(4-tertbutylbenzyl)-
4-chloro-3-ethyl-1-methyl-1Hpyrazole-5- carboxamide
| | 119168-77-3 | Acute Tox. 3 | H301 | GHS06 | H301 | |
M = 10
M = 10
|
| Acute Tox. 4 | H332 | GHS08 | H332
| STOT RE 2 | H373 (appareil digestif) (oral) | GHS09 | H373 (appareil digestif) (oral)
| Skin Sens. 1B | H317 | Dgr | H317
| Aquatic Acute 1 | H400 | |
| Aquatic Chronic 1 | H410 | | H410
| 616-211-00-1 |
proquinazid (ISO);
6-iodo-2-propoxy-3-propylquinazolin-4(3H)-one
| | 189278-12-4 | Carc. 2 | H351 | GHS08 | H351 | |
M = 1
M = 10
|
| Aquatic Acute 1 | H400 | GHS09 |
| Aquatic Chronic 1 | H410 | Wng | H410